Healthtech sector growing rapidly in the Basel Area
The investment and innovation promotion agency Basel Area Business & Innovation, previously known as BaselArea.swiss, can look back on a successful year in 2019. In this regard, positive developments in the healthtech sector and in Switzerland Innovation Park Basel Area stand out.
Annual report 2019
Last year, the Basel Area proved to be a location with a promising future. Basel Area Business & Innovation, the investment and innovation promotion agency, has supported the settlement of 30 companies in the cantons of Basel-Stadt, Basel-Landschaft and Jura. The agency’s 2019 annual report further reveals that it also supported the founding of 62 startups.
Despite the fact that, in comparison with the prior year, the number of companies settling in the area decreased by three and the number of startups by ten, the healthtech sector has defied this development to record growth. Seven out of the newly settled companies and six of those newly established are active in this area and develop health technologies, for example for personalized medicine and digitization within the industry.
The media release states that Switzerland Innovation Park Basel Area, which is operated by Basel Area Business & Innovation, enjoyed a “highly successful” year in 2019. As such, the number of companies located there increased from 13 to 32. Further successful developments include the start of construction on the new GRID Campus of Collaboration building at the main site in Allschwil BL, the inauguration of the Jura site in Courroux and the first steps toward the new site on the Novartis Campus in Basel.
Christof Klöpper, CEO of Basel Area Business & Innovation, is quoted in the press release, saying: “In order to position the Basel Area as an attractive location for the settlement of foreign companies and the founding of local startups, as well as to hold our ground in an environment where competition between locations is increasing, a strong positioning is extremely important.” For this reason, a change of name from BaselArea.swiss to Basel Area Business & Innovation was resolved. This is accompanied by a new online presence, the new slogan “More to discover” and a new logo. This logo may also be used by institutions and organizations “so that they can raise the awareness of the economic region at home and abroad and invite companies and talents to discover the potential of the Basel Area.”
Share this article
You may also be interested in
A research project is investigating the improvement in the condition of patients who have been hospitalized due to COVID-19. docdok.health based in Basel is contributing the smartphone app for the project.Read More
The Allschwil-based pharmaceutical company Idorsia receives a payment of 45 million US dollars as part of an agreement with Neurocrine Biosciences and shall also be entitled to claim milestone payments in future. Neurocrine has exercised a licensing option for a drug developed by Idorsia to treat epilepsy..Read More
Roche has received Emergency Use Authorization in the USA for an antibody test in connection with the novel coronavirus. The tests are already being distributed around the world. In May, production capacities are to already be scaled up to the high double-digit million area.Read More
Basel is valued as a location for company headquarters. In a rating from the fDi Intelligence platform of the Financial Times, Basel achieves eighth place in Europe. No other Swiss city does better.Read More